LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 80.88 | 17.25 | 1269 | 5826 | 0.2178 | 0.6681 | MN20160310_N02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 80.88 | 17.25 | 6101 | 5826 | 1.0472 | 1.0110 | MN20160310_N02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 82.85 | 17.25 | 222 | 5861 | 0.0379 | 0.3550 | MN20160310_N02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 82.85 | 17.25 | 4670 | 5861 | 0.7967 | 0.9467 | MN20160310_N02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 82.85 | 17.25 | 1326 | 5861 | 0.2262 | 0.6760 | MN20160310_N02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 82.85 | 17.25 | 6218 | 5861 | 1.0608 | 1.0141 | MN20160310_N02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 84.82 | 17.25 | 171 | 5924 | 0.0289 | 0.3130 | MN20160310_N02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 84.82 | 17.25 | 4766 | 5924 | 0.8045 | 0.9490 | MN20160310_N02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 84.82 | 17.25 | 1215 | 5924 | 0.2051 | 0.6571 | MN20160310_N02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 84.82 | 17.25 | 6377 | 5924 | 1.0764 | 1.0176 | MN20160310_N02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 86.79 | 17.25 | 80 | 6008 | 0.0133 | 0.1992 | MN20160310_N02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 86.79 | 17.25 | 4899 | 6008 | 0.8154 | 0.9522 | MN20160310_N02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 86.79 | 17.25 | 753 | 6008 | 0.1253 | 0.5639 | MN20160310_N02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 86.79 | 17.25 | 6467 | 6008 | 1.0763 | 1.0175 | MN20160310_N02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 88.76 | 17.25 | 110 | 6047 | 0.0182 | 0.2450 | MN20160310_N02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 88.76 | 17.25 | 5001 | 6047 | 0.8269 | 0.9555 | MN20160310_N02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 88.76 | 17.25 | 300 | 6047 | 0.0496 | 0.4019 | MN20160310_N02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 88.76 | 17.25 | 6656 | 6047 | 1.1005 | 1.0228 | MN20160310_N02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 90.74 | 17.25 | 68 | 6109 | 0.0111 | 0.1758 | MN20160310_N02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 90.74 | 17.25 | 5092 | 6109 | 0.8335 | 0.9574 | MN20160310_N02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 90.74 | 17.25 | 342 | 6109 | 0.0560 | 0.4229 | MN20160310_N02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 90.74 | 17.25 | 6819 | 6109 | 1.1161 | 1.0261 | MN20160310_N02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 92.71 | 17.25 | 54 | 6184 | 0.0087 | 0.1439 | MN20160310_N02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 92.71 | 17.25 | 5166 | 6184 | 0.8354 | 0.9581 | MN20160310_N02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 92.71 | 17.25 | 238 | 6184 | 0.0385 | 0.3624 | MN20160310_N02 | F04 |